HOME >> BIOLOGY >> NEWS
InfoSNM highlights advances in computer, information sciences for molecular imaging

RESTON, Va. -- The explosive growth in the power of digital computers used for molecular imaging and nuclear medicine will be showcased at SNMs 54th Annual Meeting June 26 in the Washington Convention Center in Washington, D.C. SNM, the worlds largest society for molecular imaging and nuclear medicine, debuts its InfoSNM program, offering both educational programs on information science and technology and novel uses of computers in research and education as well as in the clinic.

"The use of computers and information scienceand how they are essential to clinical data processing, image data management, education and science for molecular imaging and nuclear medicinewill be featured at InfoSNM," said SNMs Scientific Program Chair Frederic H. Fahey. "More than 4,000 doctors, technologists, scientists and pharmacists from around the world will have the opportunity to participate with this extraordinary first-time program," he added.

"Computers are an essential part for molecular imaging research and nuclear medicine procedures," said Fahey, who anticipates that the popularity of this program will increase in years to come. InfoSNM will offer computer demonstrations by vendors, computer classrooms used for commercial presentations and general computer education, and computer-based presentations on the use of information science and technology that has been developed in laboratories, said Fahey. "I am encouraged by the tremendous amount of interest and support that InfoSNM has received. Computers and information science touch so many aspects of what molecular imaging and nuclear medicine professionals do every day," he added.

From June 35, novel researchfor the clinic or research labwill be presented in six computer presentation sessions. Times have been designated for presenters to describe their work, give demonstrations and answer questions. Topics include

  • the development of a PET/CT database of patient information
    '"/>


Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
9-May-2007


Page: 1 2

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Landmark study highlights complex genetic risk factors behind type 2 diabetes
9. Other highlights from the April 18 Journal of the National Cancer Institute
10. Cold Spring Harbor Protocols highlights reliable methods for gene and protein analyses
11. Other highlights from the March 21 JNCI

Post Your Comments:
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: